Hayashi J, Kishihara Y, Yoshimura E, Tani Y, Yamaji K, Ikematsu H, Ishiko H, Kashiwagi S
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan.
J Infect. 1995 May;30(3):235-9. doi: 10.1016/s0163-4453(95)90785-8.
To compare the levels of hepatitis C virus (HCV) viraemia in carriers of the same genotype in various stages of chronic HCV infection, we quantified the amount of HCV RNA by competitive polymerase chain reaction and determined HCV genotype using type-specific primers. The study population included 255 patients with chronic HCV infection (asymptomatic 33, chronic hepatitis 141, liver cirrhosis 50, hepatocellular carcinoma 31). Of these 255, the prevalence of HCV RNA genotype II was 67.8%, genotype III, 17.3% and genotype IV, 14.9%; no genotype I was found. The level of HCV RNA (logarithmic transformed copy numbers per 50 microliters of serum) was significantly higher in subjects of genotype II than in those of genotypes III or IV (mean titre 5.8 +/- 1.0 vs. 5.1 +/- 1.2 and 4.8 +/- 1.1, P < 0.05, respectively). There was no significant difference in the level of HCV RNA between genotypes III and IV. Of 173 patients of genotype II, there were no significant differences between the level of HCV RNA and the stage of liver disease or in the level of HCV RNA by age. Of the 129 with genotype II with a history of blood transfusion, there was no significant difference between the level of HCV RNA of patients with and without a history of transfusion or between that of patients with a history of blood transfusion and the time elapsed since blood transfusion. The level of HCV viraemia depended on the genotype of HCV RNA and did not correlate to age or to the stage of liver disease.(ABSTRACT TRUNCATED AT 250 WORDS)
为比较慢性丙型肝炎病毒(HCV)感染不同阶段相同基因型携带者的HCV病毒血症水平,我们通过竞争性聚合酶链反应定量HCV RNA的量,并使用型特异性引物确定HCV基因型。研究人群包括255例慢性HCV感染患者(无症状者33例、慢性肝炎患者141例、肝硬化患者50例、肝细胞癌患者31例)。在这255例患者中,HCV RNA基因型II的患病率为67.8%,基因型III为17.3%,基因型IV为14.9%;未发现基因型I。基因型II受试者的HCV RNA水平(每50微升血清的对数转换拷贝数)显著高于基因型III或IV受试者(平均滴度分别为5.8±1.0 vs. 5.1±1.2和4.8±1.1,P<0.05)。基因型III和IV之间的HCV RNA水平无显著差异。在173例基因型II患者中,HCV RNA水平与肝病阶段之间或按年龄分组的HCV RNA水平之间均无显著差异。在129例有输血史的基因型II患者中,有输血史和无输血史患者的HCV RNA水平之间,以及有输血史患者的HCV RNA水平与输血后经过的时间之间均无显著差异。HCV病毒血症水平取决于HCV RNA的基因型,与年龄或肝病阶段无关。(摘要截短于250字)